Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 373

1.

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.

Salem RM, Todd JN, Sandholm N, Cole JB, Chen WM, Andrews D, Pezzolesi MG, McKeigue PM, Hiraki LT, Qiu C, Nair V, Di Liao C, Cao JJ, Valo E, Onengut-Gumuscu S, Smiles AM, McGurnaghan SJ, Haukka JK, Harjutsalo V, Brennan EP, van Zuydam N, Ahlqvist E, Doyle R, Ahluwalia TS, Lajer M, Hughes MF, Park J, Skupien J, Spiliopoulou A, Liu A, Menon R, Boustany-Kari CM, Kang HM, Nelson RG, Klein R, Klein BE, Lee KE, Gao X, Mauer M, Maestroni S, Caramori ML, de Boer IH, Miller RG, Guo J, Boright AP, Tregouet D, Gyorgy B, Snell-Bergeon JK, Maahs DM, Bull SB, Canty AJ, Palmer CNA, Stechemesser L, Paulweber B, Weitgasser R, Sokolovska J, Rovīte V, Pīrāgs V, Prakapiene E, Radzeviciene L, Verkauskiene R, Panduru NM, Groop LC, McCarthy MI, Gu HF, Möllsten A, Falhammar H, Brismar K, Martin F, Rossing P, Costacou T, Zerbini G, Marre M, Hadjadj S, McKnight AJ, Forsblom C, McKay G, Godson C, Maxwell AP, Kretzler M, Susztak K, Colhoun HM, Krolewski A, Paterson AD, Groop PH, Rich SS, Hirschhorn JN, Florez JC; SUMMIT Consortium, DCCT/EDIC Research Group, GENIE Consortium.

J Am Soc Nephrol. 2019 Sep 19. pii: ASN.2019030218. doi: 10.1681/ASN.2019030218. [Epub ahead of print]

PMID:
31537649
2.

The long-term incidence of hospitalization for ketoacidosis in adults with established T1D - a prospective cohort study.

Thomas M, Harjutsalo V, Feodoroff M, Forsblom C, Gordin D, Groop PH.

J Clin Endocrinol Metab. 2019 Sep 14. pii: dgz003. doi: 10.1210/clinem/dgz003. [Epub ahead of print]

PMID:
31529090
3.

CACNB2 is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes.

Vuori N, Sandholm N, Kumar A, Hietala K, Syreeni A, Forsblom C, Juuti-Uusitalo K, Skottman H, Imamura M, Maeda S, Summanen PA, Lehto M, Groop PH; FinnDiane Study.

Diabetes. 2019 Aug 22. pii: db190130. doi: 10.2337/db19-0130. [Epub ahead of print]

PMID:
31439644
4.

Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes.

Ahola AJ, Forsblom C, Harjutsalo V, Groop PH; FinnDiane Study Group.

Diabetes Res Clin Pract. 2019 Aug 16;155:107818. doi: 10.1016/j.diabres.2019.107818. [Epub ahead of print]

PMID:
31425769
5.

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease.

Palanca A, Castelblanco E, Betriu À, Perpiñán H, Soldevila B, Valdivielso JM, Bermúdez-Lopez M, Puig-Jové C, Puig-Domingo M, Groop PH, Fernández E, Alonso N, Mauricio D.

Cardiovasc Diabetol. 2019 Jul 19;18(1):93. doi: 10.1186/s12933-019-0897-y.

6.

The role of blood pressure in risk of ischemic and hemorrhagic stroke in type 1 diabetes.

Hägg-Holmberg S, Dahlström EH, Forsblom CM, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH, Thorn LM; FinnDiane Study Group.

Cardiovasc Diabetol. 2019 Jul 9;18(1):88. doi: 10.1186/s12933-019-0891-4.

7.

Dietary intake in type 1 diabetes at different stages of diabetic kidney disease.

Ahola AJ, Forsblom C, Harjutsalo V, Groop PH.

Diabetes Res Clin Pract. 2019 Jul 1:107775. doi: 10.1016/j.diabres.2019.06.016. [Epub ahead of print]

PMID:
31271811
8.

Biomarker panels associated with progression of renal disease in type 1 diabetes.

Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM; FinnDiane Study Group and the Scottish Diabetes Research Network (SDRN) Type 1 Bioresource Collaboration.

Diabetologia. 2019 Sep;62(9):1616-1627. doi: 10.1007/s00125-019-4915-0. Epub 2019 Jun 20.

9.

Physical Activity in the Prevention of Development and Progression of Kidney Disease in Type 1 Diabetes.

Pongrac Barlovic D, Tikkanen-Dolenc H, Groop PH.

Curr Diab Rep. 2019 May 31;19(7):41. doi: 10.1007/s11892-019-1157-y. Review.

10.

Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes.

Wadén JM, Dahlström EH, Elonen N, Thorn LM, Wadén J, Sandholm N, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2019 Jul;62(7):1268-1274. doi: 10.1007/s00125-019-4883-4. Epub 2019 May 24.

11.

Insulin exposure mitigates the increase of arterial stiffness in patients with type 2 diabetes and albuminuria: an exploratory analysis.

Gordin D, Saraheimo M, Tuomikangas J, Soro-Paavonen A, Forsblom C, Paavonen K, Steckel-Hamann B, Harjutsalo V, Nicolaou L, Pavo I, Koivisto V, Groop PH.

Acta Diabetol. 2019 May 22. doi: 10.1007/s00592-019-01351-4. [Epub ahead of print]

PMID:
31119456
12.

Body mass index and mortality in individuals with type 1 diabetes.

Dahlström EH, Sandholm N, Forsblom CM, Thorn LM, Jansson FJ, Harjutsalo V, Groop PH; FinnDiane Study Group.

J Clin Endocrinol Metab. 2019 Apr 29. pii: jc.2019-00042. doi: 10.1210/jc.2019-00042. [Epub ahead of print]

PMID:
31034018
13.
14.

Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study.

Finne P, Groop PH, Arffman M, Kervinen M, Helve J, Grönhagen-Riska C, Sund R.

Diabetes Care. 2019 Apr;42(4):539-544. doi: 10.2337/dc18-1485. Epub 2019 Jan 28.

PMID:
30692239
15.

Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.

Syreeni A, Sandholm N, Cao J, Toppila I, Maahs DM, Rewers MJ, Snell-Bergeon JK, Costacou T, Orchard TJ, Caramori ML, Mauer M, Klein BEK, Klein R, Valo E, Parkkonen M, Forsblom C, Harjutsalo V, Paterson AD; DCCT/EDIC Research Group, Groop PH; FinnDiane Study Group.

Diabetes. 2019 Apr;68(4):858-867. doi: 10.2337/db18-0573. Epub 2019 Jan 23.

PMID:
30674623
16.

Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes.

Thorn LM, Shams S, Gordin D, Liebkind R, Forsblom C, Summanen P, Hägg-Holmberg S, Tatlisumak T, Salonen O, Putaala J, Martola J, Groop PH; FinnDiane Study Group.

Diabetes Care. 2019 Feb;42(2):327-330. doi: 10.2337/dc18-1302. Epub 2018 Dec 14.

PMID:
30552131
17.

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.

Ahluwalia TS, Schulz CA, Waage J, Skaaby T, Sandholm N, van Zuydam N, Charmet R, Bork-Jensen J, Almgren P, Thuesen BH, Bedin M, Brandslund I, Christensen CK, Linneberg A, Ahlqvist E, Groop PH, Hadjadj S, Tregouet DA, Jørgensen ME, Grarup N, Pedersen O, Simons M, Groop L, Orho-Melander M, McCarthy MI, Melander O, Rossing P, Kilpeläinen TO, Hansen T.

Diabetologia. 2019 Feb;62(2):292-305. doi: 10.1007/s00125-018-4783-z. Epub 2018 Dec 13.

18.

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria.

Cooper ME, Perkovic V, Groop PH, Hocher B, Hehnke U, Meinicke T, Koitka-Weber A, van der Walt S, von Eynatten M.

J Hypertens. 2019 Jun;37(6):1294-1300. doi: 10.1097/HJH.0000000000002032.

19.

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.

Pollack S, Igo RP Jr, Jensen RA, Christiansen M, Li X, Cheng CY, Ng MCY, Smith AV, Rossin EJ, Segrè AV, Davoudi S, Tan GS, Chen YI, Kuo JZ, Dimitrov LM, Stanwyck LK, Meng W, Hosseini SM, Imamura M, Nousome D, Kim J, Hai Y, Jia Y, Ahn J, Leong A, Shah K, Park KH, Guo X, Ipp E, Taylor KD, Adler SG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes-Eye Research Group, DCCT/EDIC Research Group, Lee IT, Sheu WH, Kubo M, Takahashi A, Hadjadj S, Marre M, Tregouet DA, Mckean-Cowdin R, Varma R, McCarthy MI, Groop L, Ahlqvist E, Lyssenko V, Agardh E, Morris A, Doney ASF, Colhoun HM, Toppila I, Sandholm N, Groop PH, Maeda S, Hanis CL, Penman A, Chen CJ, Hancock H, Mitchell P, Craig JE, Chew EY, Paterson AD, Grassi MA, Palmer C, Bowden DW, Yaspan BL, Siscovick D, Cotch MF, Wang JJ, Burdon KP, Wong TY, Klein BEK, Klein R, Rotter JI, Iyengar SK, Price AL, Sobrin L.

Diabetes. 2019 Feb;68(2):441-456. doi: 10.2337/db18-0567. Epub 2018 Nov 28.

20.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.

Diabetes Care. 2019 Jan;42(1):93-101. doi: 10.2337/dc18-1369. Epub 2018 Nov 19.

PMID:
30455333
21.

Associations of dietary macronutrient and fibre intake with glycaemia in individuals with Type 1 diabetes.

Ahola AJ, Harjutsalo V, Forsblom C, Saraheimo M, Groop PH; Finnish Diabetic Nephropathy Study.

Diabet Med. 2018 Nov 13. doi: 10.1111/dme.13863. [Epub ahead of print]

PMID:
30426566
22.

Long-term Mortality After Kidney Transplantation in a Nationwide Cohort of Patients With Type 1 Diabetes in Finland.

Ortiz F, Harjutsalo V, Helanterä I, Lempinen M, Forsblom C, Groop PH.

Diabetes Care. 2019 Jan;42(1):55-61. doi: 10.2337/dc18-1029. Epub 2018 Nov 2.

PMID:
30389672
23.

Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.

Polianskyte-Prause Z, Tolvanen TA, Lindfors S, Dumont V, Van M, Wang H, Dash SN, Berg M, Naams JB, Hautala LC, Nisen H, Mirtti T, Groop PH, Wähälä K, Tienari J, Lehtonen S.

FASEB J. 2019 Feb;33(2):2858-2869. doi: 10.1096/fj.201800529RR. Epub 2018 Oct 15.

24.

Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.

Wanner C, Heerspink HJL, Zinman B, Inzucchi SE, Koitka-Weber A, Mattheus M, Hantel S, Woerle HJ, Broedl UC, von Eynatten M, Groop PH; EMPA-REG OUTCOME Investigators.

J Am Soc Nephrol. 2018 Nov;29(11):2755-2769. doi: 10.1681/ASN.2018010103. Epub 2018 Oct 12.

PMID:
30314978
25.

Association between diet and measures of arterial stiffness in type 1 diabetes - Focus on dietary patterns and macronutrient substitutions.

Ahola AJ, Gordin D, Forsblom C, Groop PH; FinnDiane Study Group.

Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1166-1172. doi: 10.1016/j.numecd.2018.07.003. Epub 2018 Jul 17.

PMID:
30292475
26.

The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders.

Lehto M, Groop PH.

Front Endocrinol (Lausanne). 2018 Sep 19;9:553. doi: 10.3389/fendo.2018.00553. eCollection 2018. Review.

27.

The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.

Pongrac Barlovic D, Harjutsalo V, Gordin D, Kallio M, Forsblom C, King G, Groop PH; FinnDiane Study Group.

Diabetes Care. 2018 Dec;41(12):2487-2494. doi: 10.2337/dc18-0476. Epub 2018 Sep 26.

PMID:
30257963
28.

Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes.

Feodoroff M, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 Dec;61(12):2580-2589. doi: 10.1007/s00125-018-4725-9. Epub 2018 Sep 18.

PMID:
30229273
29.

Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes.

Haukka JK, Sandholm N, Forsblom C, Cobb JE, Groop PH, Ferrannini E.

Sci Rep. 2018 Sep 14;8(1):13853. doi: 10.1038/s41598-018-32085-y.

30.

A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.

Meng W, Shah KP, Pollack S, Toppila I, Hebert HL, McCarthy MI, Groop L, Ahlqvist E, Lyssenko V, Agardh E, Daniell M, Kaidonis G, Craig JE, Mitchell P, Liew G, Kifley A, Wang JJ, Christiansen MW, Jensen RA, Penman A, Hancock HA, Chen CJ, Correa A, Kuo JZ, Li X, Chen YI, Rotter JI, Klein R, Klein B, Wong TY, Morris AD, Doney ASF, Colhoun HM, Price AL, Burdon KP, Groop PH, Sandholm N, Grassi MA, Sobrin L, Palmer CNA; Wellcome Trust Case Control Consortium 2 (WTCCC2), Surrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools (SUMMIT) study group.

Acta Ophthalmol. 2018 Nov;96(7):e811-e819. doi: 10.1111/aos.13769. Epub 2018 Sep 4.

31.

Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes.

Sandholm N, Haukka JK, Toppila I, Valo E, Harjutsalo V, Forsblom C, Groop PH.

Sci Rep. 2018 Aug 17;8(1):12408. doi: 10.1038/s41598-018-29211-1.

32.

Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes.

Palanca A, Castelblanco E, Perpiñán H, Betriu À, Soldevila B, Valdivielso JM, Bermúdez M, Duran X, Fernández E, Puig-Domingo M, Groop PH, Alonso N, Mauricio D.

Atherosclerosis. 2018 Sep;276:50-57. doi: 10.1016/j.atherosclerosis.2018.07.018. Epub 2018 Jul 19.

PMID:
30032025
33.

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.

Harjutsalo V, Thomas MC, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetes Obes Metab. 2018 Dec;20(12):2759-2767. doi: 10.1111/dom.13456. Epub 2018 Aug 7.

PMID:
29962015
34.

Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes.

Lithovius R, Gordin D, Forsblom C, Saraheimo M, Harjutsalo V, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 Sep;61(9):1935-1945. doi: 10.1007/s00125-018-4648-5. Epub 2018 May 24.

PMID:
29797021
35.

Adherence to special diets and its association with meeting the nutrient recommendations in individuals with type 1 diabetes.

Ahola AJ, Forsblom C, Groop PH.

Acta Diabetol. 2018 Aug;55(8):843-851. doi: 10.1007/s00592-018-1159-2. Epub 2018 May 18.

PMID:
29777369
36.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

37.

Electrocardiographic changes before and after successful kidney transplantation and associations with cardiovascular and mortality outcomes.

Paajanen H, Helanterä I, Kaartinen K, Nikus K, Eskola M, Groop PH, Koskinen P.

Clin Transplant. 2018 May;32(5):e13242. doi: 10.1111/ctr.13242. Epub 2018 Apr 11.

PMID:
29573467
38.

Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes.

Stutz B, Ahola AJ, Harjutsalo V, Forsblom C, Groop PH; FinnDiane Study Group.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):470-476. doi: 10.1016/j.numecd.2018.01.011. Epub 2018 Feb 1.

PMID:
29501444
39.

Association between depressive symptoms and dietary intake in patients with type 1 diabetes.

Ahola AJ, Forsblom C, Groop PH; FinnDiane Study Group.

Diabetes Res Clin Pract. 2018 May;139:91-99. doi: 10.1016/j.diabres.2018.02.018. Epub 2018 Feb 21.

PMID:
29475022
40.

Genetic basis of diabetic kidney disease and other diabetic complications.

Sandholm N, Groop PH.

Curr Opin Genet Dev. 2018 Jun;50:17-24. doi: 10.1016/j.gde.2018.01.002. Epub 2018 Feb 14. Review.

PMID:
29453109
41.

Diabetes and intracerebral hemorrhage: baseline characteristics and mortality.

Liebkind R, Gordin D, Strbian D, Meretoja A, Thorn LM, Hägg-Holmberg S, Forsblom C, Tatlisumak T, Groop PH, Putaala J.

Eur J Neurol. 2018 Jun;25(6):825-832. doi: 10.1111/ene.13603. Epub 2018 Mar 26.

PMID:
29443444
42.

Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study.

Jansson FJ, Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Elonen N, Ahola AJ, Saraheimo M, Groop PH; FinnDiane Study Group.

Diabetologia. 2018 May;61(5):1203-1211. doi: 10.1007/s00125-018-4564-8. Epub 2018 Feb 8.

PMID:
29423580
43.

Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes.

Gordin D, Harjutsalo V, Tinsley L, Fickweiler W, Sun JK, Forsblom C, Amenta PS, Pober D, D'Eon S, Khatri M, Stillman IE, Groop PH, Keenan HA, King GL.

Diabetes Care. 2018 Apr;41(4):815-822. doi: 10.2337/dc17-2250. Epub 2018 Jan 31.

44.

Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria-Separating the Contribution of Early and Late Risks.

Groop PH, Thomas M, Feodoroff M, Forsblom C, Harjutsalo V; FinnDiane Study Group.

Diabetes Care. 2018 Apr;41(4):748-754. doi: 10.2337/dc17-1618. Epub 2018 Jan 29.

PMID:
29378776
45.

Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes.

Helve J, Sund R, Arffman M, Harjutsalo V, Groop PH, Grönhagen-Riska C, Finne P.

Diabetes Care. 2018 Mar;41(3):434-439. doi: 10.2337/dc17-2364. Epub 2017 Dec 20.

PMID:
29263163
46.

Physical Activity Reduces Risk of Premature Mortality in Patients With Type 1 Diabetes With and Without Kidney Disease.

Tikkanen-Dolenc H, Wadén J, Forsblom C, Harjutsalo V, Thorn LM, Saraheimo M, Elonen N, Tikkanen HO, Groop PH; FinnDiane Study Group.

Diabetes Care. 2017 Dec;40(12):1727-1732. doi: 10.2337/dc17-0615. Epub 2017 Oct 16.

PMID:
29038314
47.

Serum Insulin Bioassay Reflects Insulin Sensitivity and Requirements in Type 1 Diabetes.

Janssen JAMJL, Llauradó G, Varewijck AJ, Groop PH, Forsblom C, Fernández-Veledo S, van den Dungen ESR, Vendrell J, Hofland LJ, Yki-Järvinen H.

J Clin Endocrinol Metab. 2017 Oct 1;102(10):3814-3821. doi: 10.1210/jc.2017-00892.

PMID:
28938465
48.

Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes.

Hägg-Holmberg S, Thorn LM, Forsblom CM, Gordin D, Elonen N, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH; FinnDiane Study Group.

Diabetes Care. 2017 Oct;40(10):1394-1400. doi: 10.2337/dc17-0681. Epub 2017 Aug 15.

PMID:
28811283
49.

Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease.

Mardinoglu A, Stančáková A, Lotta LA, Kuusisto J, Boren J, Blüher M, Wareham NJ, Ferrannini E, Groop PH, Laakso M, Langenberg C, Smith U.

Cell Metab. 2017 Aug 1;26(2):281-283. doi: 10.1016/j.cmet.2017.07.006.

50.

Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity.

Ahola AJ, Lassenius MI, Forsblom C, Harjutsalo V, Lehto M, Groop PH.

Sci Rep. 2017 Jul 26;7(1):6511. doi: 10.1038/s41598-017-06885-7.

Supplemental Content

Support Center